1. |
Developing countries urged to step up health investment |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 438,
2003,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
2. |
Less toxicity with pemetrexed spells savings in NSCLC |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 438,
2003,
Page 3-4
L Hunt,
Preview
|
|
摘要:
Currently, docetaxel is the standard second-line treatment for patients with non-small-cell lung cancer (NSCLC) with a good performance status, based on phase III randomised studies showing improved outcomes compared with ifosfamide, vinorelbine or best supportive care. However, in phase II studies, pemetrexed has shown clinically-relevant activity against NSCLC as initial or second-line therapy. New data presented at the 12th European Cancer Conference (ECCO) [Copenhagen, Denmark; September 2003] suggests that not only is pemetrexed similar to docetaxel in terms of clinical efficacy, it also costs less and results in fewer drug-related adverse events.1,2
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
3. |
Streamlining antibacterial therapy in CAP not cost saving |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 438,
2003,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
4. |
Antineoplastics and mucositis: clinical and economic cost high |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 438,
2003,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
5. |
Biological agents drive costs in RA |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 438,
2003,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
6. |
Hospitalisation rates for patients with HIV/HCV*co-infection increased significantly between 1995 and 2000, |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 438,
2003,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
7. |
β-Blocker use increased but improvement required in acute MI |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 438,
2003,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
8. |
A training programme implemented in primary care"did not ultimately affect the weight"of a cohort of obese patients, |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 438,
2003,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
9. |
QOL outcomes complex after prostate cancer treatment |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 438,
2003,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
10. |
Reference pricing in Spain attacked by pharma industry |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 438,
2003,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|